Home > Insider Trading > Filing (0001209191-22-007929)

Filing Details

Accession Number:: 0001209191-22-007929
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-02-08 21:31:25
Reporting Period:: 2022-02-06

Accepted Time:: 2022-02-08 21:31:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596783	Catalent Inc.	CTLT	Pharmaceutical Preparations (2834)	208737688

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1775433	Peter Zippelius	11111 Santa Monica Blvd. Suite 2000 Los Angeles CA 90025		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-02-06	487,092	$102.65	4,330,462	No	4	S	Indirect	See footnote.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	7,830	Direct

Footnotes

On February 6, 2022, Green Equity Investors VII, L.P. ("GEI VII"), Green Equity Investors Side VII, L.P. ("GEI Side VII"), LGP Associates VII-A LLC ("Associates VII-A") and LGP Associates VII-B LLC ("Associates VII-B") entered into a stock purchase agreement to sell 487,092 shares of Common Stock of the Issuer, par value $0.01 per share (the "Common Stock"). Of the shares reported, 217,645 shares were sold by GEI VII, 257,176 shares were sold by GEI Side VII, 1,231 shares were sold by Associates VII-A, and 11,040 shares were sold by Associates VII-B.
Represents shares of Common Stock owned by GEI VII, GEI Side VII, Associates VII-A, and Associates VII-B. Of the shares reported, 1,934,955 shares are owned by GEI VII, 2,286,407 shares are owned by GEI Side VII, 10,944 shares are owned by Associates VII-A, and 98,156 shares are owned by Associates VII-B. In a prior report, the reported shares of Common Stock held by GEI VII, GEI Side VII, Associates VII-A, and Associates VII-B were overstated due to an inadvertent calculation error upon the conversion of 384,777 shares of Series A Convertible Preferred Stock to Common Stock. This report reflects the correct amount of shares held by such persons following the reported transaction.
Mr. Zippelius directly (whether through ownership or position), or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the shares owned by GEI VII, GEI Side VII, Associates VII-A, and Associates VII-B. Mr. Zippelius disclaims beneficial ownership of the shares held by each of GEI VII, GEI Side VII, Associates VII-A, and Associates VII-B except to the extent of his pecuniary interest therein, and this report shall not otherwise be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Represents shares of Common Stock and shares of Common Stock underlying restricted stock units. The shares reported on this row are held by Mr. Zippelius for the benefit of Leonard Green & Partners, L.P. Each restricted stock unit represents the right to receive one share of Common Stock. Of the 7,830 shares of Common Stock reported, 1,402 will vest on the earlier of October 28, 2022 and the date of the Issuer's fiscal 2022 annual meeting of shareholders.